# AZD7451 for Recurrent Gliomas

> **NCT01468324** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 14 (actual)

## Conditions studied

- Glioblastoma Multiforme

## Interventions

- **DRUG:** AZD7451

## Key facts

- **NCT ID:** NCT01468324
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10-05
- **Primary completion:** 2014-04-23
- **Final completion:** 2014-04-23
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2019-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01468324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01468324, "AZD7451 for Recurrent Gliomas". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01468324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*